Cosmetic Ingredient Loaded Glyconanoparticle Formulation Service
Overview of Cosmetic Ingredient Loaded Glyconanoparticle Formulation
At CD BioGlyco, we pride ourselves on pioneering advanced solutions in the formulation of cosmetic ingredients using our innovative GlycoNano™ Platform. The cosmetic industry continuously demands more sophisticated and efficient delivery systems to enhance the efficacy and stability of active ingredients. cosmetic ingredient loaded glyconanoparticle formulation service is essential in meeting these demands by leveraging glyconanotechnology to encapsulate and deliver bioactive cosmetic ingredients. Our GlycoNano™ platform serves as the foundation for creating these advanced delivery systems and seamlessly integrates with our specialized formulation services. Glyconanoparticle Formulation Services represent our commitment to providing tailored solutions, offering a detailed, custom approach to encapsulating a wide range of cosmetic ingredients within glyconanoparticles, ensuring enhanced stability and bioavailability.
Unleash Beauty with Our Cosmetic Ingredient Loaded Glyconanoparticle Formulation Service
Our technical services focus on the formulation of glyconanoparticles loaded with various cosmetic ingredients, including proteins, peptides, moisturizing factors, barrier repair components, and sunscreens. By employing sophisticated nano-encapsulation and synthesis techniques, we ensure precise loading, sustained release, and enhanced skin permeability of these ingredients.

- Ingredient Identification and Analysis: We start by identifying the cosmetic ingredients that require enhanced delivery: be it antioxidants, peptides, or any other active compounds. An in-depth analysis of the physicochemical properties of these ingredients is carried out.
- Glyconanoparticle Development: Utilizing insights from the analysis phase, we design glyconanoparticles that encapsulate the cosmetic ingredients. This involves engineered binding sites that improve the stability and release profiles of these ingredients. Then, we use methods like emulsion polymerization or nanoprecipitation, the glyconanoparticles are synthesized. The process ensures high encapsulation efficiency and stability while maintaining ingredient integrity.
- Characterization: Advanced characterization techniques like dynamic light scattering (DLS), zeta potential analysis, and electron microscopy are employed to analyze particle size, surface charge, and morphological structures to ensure consistency and efficacy.
- Preclinical Evaluation: Before proceeding to formulation, we conduct in vitro skin models to assess permeability and release rates. This preclinical service ensures that the nanoparticles meet the desired safety.
Protein and Peptide Loaded Glyconanoparticle Formulation Service
For protein and peptide-based cosmetic ingredients, we employ advanced nano-encapsulation techniques to achieve efficient loading and stable delivery through precise control of the particle size, surface charge, and hydrophobicity of glyconanoparticles. By leveraging electrostatic interactions, hydrophobic interactions, and other principles, we tightly bind the protein and peptide ingredients to the glyconanoparticles while maintaining their biological activity. Characterization using transmission electron microscopy (TEM) and DLS ensures uniform particle size and good dispersion. Additionally, in vitro cellular experiments assess the biocompatibility and delivery efficiency of the nanoparticles, providing data support for subsequent formulation optimization.
Moisturizing and Barrier Repair Ingredient Loaded Glyconanoparticle Formulation Service
For moisturizing and barrier repair cosmetic ingredients, we design glyconanoparticles with excellent moisturizing properties and barrier repair functions. By optimizing the composition and structure of the glyconanoparticles, we achieve precise loading and sustained release of moisturizing factors and barrier repair components. Using emulsification-solvent evaporation, self-assembly, and other techniques, we combine moisturizing and barrier repair ingredients with glyconanoparticles to form stable nanocomposite systems. Characterization through Fourier transform infrared spectroscopy (FTIR) and X-ray diffraction (XRD) verifies their composition and structure. Furthermore, skin permeation experiments and moisturizing performance tests evaluate the skin permeability and moisturizing effect of the nanocomposite systems.
Sunscreen Loaded Glyconanoparticle Formulation Service
In the delivery of sunscreen cosmetic ingredients, we leverage the UV absorption and scattering properties of glyconanoparticles to design nanocomposite systems with efficient sunscreen functionality. Using chemical precipitation, sol-gel, and other techniques, we combine sunscreen ingredients with glyconanoparticles to form nanoparticles with excellent sunscreen performance. UV-Vis spectrophotometry tests the sunscreen performance of the nanoparticles to ensure they meet relevant standards. Additionally, skin irritation tests and photostability tests assess the skin safety and photostability of the nanoparticles.
Other Functional Ingredient Loaded Glyconanoparticle Formulation Service
Beyond the aforementioned services, we also offer customized services for loading other functional cosmetic ingredients into glyconanoparticles. Based on specific client needs, we design glyconanoparticles with whitening, anti-aging, antioxidant, and other functionalities. Using advanced nano-synthesis techniques, we combine functional cosmetic ingredients with glyconanoparticles to form nanocomposite systems with specific functions. Characterization and performance testing using TEM, high-performance liquid chromatography (HPLC), and other techniques ensure that the nanocomposite systems meet client requirements.
Applications of Cosmetic Ingredient Loaded Glyconanoparticle Formulation
- The glyconanoparticle formulation can be used to develop high-performance anti-aging products by effectively delivering peptides and other rejuvenating agents to the skin.
- The glyconanoparticle formulation can be used to create sunscreens with enhanced UV protection.
- The glyconanoparticle formulation can be used to formulate moisturizing products that deeply hydrate the skin by encapsulating and delivering humectants and other moisturizing factors.
Advantages
- Efficient active ingredient utilization: Our services significantly increase the bioavailability of active ingredients in cosmetics.
- Personalized customization service: We provide one-to-one personalized customization service and design a unique cosmetic ingredient loaded glyconanoparticle formulation solution based on the client's specific needs and goals.
- One-stop solution: We provide a one-stop solution from formulation design to development and preparation.
Publication
Published: 2022
Journal: Molecules
IF: 4.2
Results: The article discusses the role of nanoparticles in cosmetics, emphasizing their potential for enhancing active ingredient delivery. These nanoparticles address challenges such as solubility, stability, and controlled release in cosmetic formulations. Despite offering these advantages, glyconanoparticles also introduce issues of cost, shelf life, and safety, leading to regulatory challenges. In the U.S., the FDA endorses biosafety studies, unlike the EU with stricter regulations.
Fig.1 Nanocarriers as active ingredients enhancers in the cosmetic industry. (Oliveira, et al., 2022)
Our Services

Glycol Nanohydrogel Development Service
We offer both Natural Polymer-based and Synthetic Polymer-based glycol nanohydrogel development services, which are intricately linked to our cosmetic ingredient loaded glyconanoparticle formulation service. By leveraging our expertise in creating nanohydrogels, we effectively encapsulate and stabilize cosmetic ingredients within glyconanoparticles, enhancing their delivery and efficacy in various cosmetic applications.
Frequently Asked Questions
- What is the cosmetic ingredient loaded glyconanoparticle formulation service and what advantages does it bring to my study?
Cosmetic ingredient loaded glyconanoparticle formulation service is a service that uses nanotechnology to load cosmetic active ingredients into glyconanoparticles. This service significantly improves the stability and bioavailability of active ingredients, making them more easily absorbed into the skin and effective. Through this service, your products will have higher penetration, stronger efficacy, and longer-lasting skin care effects. - What will you do if I encounter a problem or need technical support while using your service?
We take our clients' feedback and needs very seriously. If you encounter problems or need technical support while using our services, our professional team is ready to help you. You can contact us by phone, email, or online chat, and our experts will answer your questions and provide solutions as soon as possible. In addition, we communicate with clients regularly to understand your needs and feedback in order to optimize our services continuously.
At CD BioGlyco, our cosmetic ingredient loaded glyconanoparticle formulation service specializes in the encapsulation of a wide range of cosmetic ingredients within glyconanoparticles, utilizing advanced nano-technologies to enhance their stability, delivery, and efficacy. We offer customized solutions tailored to meet specific client needs. Welcome to contact us for more information and collaboration opportunities.
Reference
- Oliveira, C.; et al. Nanocarriers as active ingredients enhancers in the cosmetic industry—the european and north america regulation challenges. Molecules. 2022, 27(5): 1669.
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform





